Sigma Planning Corp Trims Stake in Astera Labs, Inc. $ALAB

Key Points

• Sigma Planning Corp cut its stake in Astera Labs by 82.9% in Q4, selling 18,972 shares and retaining 3,918 shares valued at $652,000.
• Astera Labs topped Q1 estimates (EPS $0.61 vs. $0.54; revenue $308.4M, up 93.5% YoY), raised Q2 guidance to $0.68–0.70 EPS and ~$355–365M revenue, and holds a consensus “Moderate Buy” with a $199.20 price target.
• There has been heavy insider selling recently — Director Manuel Alba sold 183,000 shares for about $19.7M, and insiders disposed of 1,064,888 shares (~$150.8M) in the last 90 days, while insiders still own 12.5% of the stock.

Sigma Planning Corp lowered its position in Astera Labs, Inc. (NASDAQ:ALAB - Free Report) by 82.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,918 shares of the company's stock after selling 18,972 shares during the quarter. Sigma Planning Corp's holdings in Astera Labs were worth $652,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. Perigon Wealth Management LLC increased its stake in Astera Labs by 6.2% in the 4th quarter. Perigon Wealth Management LLC now owns 1,252 shares of the company's stock worth $208,000 after buying an additional 73 shares during the period. Clearstead Advisors LLC increased its stake in Astera Labs by 13.6% in the 3rd quarter. Clearstead Advisors LLC now owns 636 shares of the company's stock worth $125,000 after buying an additional 76 shares during the period. Sound Income Strategies LLC increased its stake in Astera Labs by 9.2% in the 4th quarter. Sound Income Strategies LLC now owns 902 shares of the company's stock worth $164,000 after buying an additional 76 shares during the period. Venturi Wealth Management LLC increased its stake in Astera Labs by 2.6% in the 4th quarter. Venturi Wealth Management LLC now owns 3,284 shares of the company's stock worth $546,000 after buying an additional 84 shares during the period. Finally, Great Valley Advisor Group Inc. increased its stake in Astera Labs by 2.2% in the 2nd quarter. Great Valley Advisor Group Inc. now owns 4,119 shares of the company's stock worth $372,000 after buying an additional 90 shares during the period. Hedge funds and other institutional investors own 60.47% of the company's stock.

Insider Buying and Selling at Astera Labs

In other news, Director Manuel Alba sold 183,000 shares of the business's stock in a transaction dated Wednesday, April 1st. The shares were sold at an average price of $107.61, for a total value of $19,692,630.00. Following the completion of the sale, the director owned 319,863 shares in the company, valued at approximately $34,420,457.43. The trade was a 36.39% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan A. Dyckerhoff sold 3,757 shares of the business's stock in a transaction dated Monday, April 20th. The shares were sold at an average price of $175.12, for a total transaction of $657,925.84. Following the completion of the sale, the director owned 67,144 shares of the company's stock, valued at approximately $11,758,257.28. This represents a 5.30% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 1,064,888 shares of company stock worth $150,764,723. 12.50% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on the stock. Barclays set a $165.00 price target on shares of Astera Labs in a research note on Thursday, January 15th. Stifel Nicolaus set a $236.00 price target on shares of Astera Labs in a research note on Friday. UBS Group assumed coverage on shares of Astera Labs in a research note on Tuesday, April 21st. They issued a "neutral" rating and a $180.00 price target on the stock. Rothschild & Co Redburn assumed coverage on shares of Astera Labs in a research note on Friday. They issued a "neutral" rating and a $153.00 price target on the stock. Finally, Citigroup assumed coverage on shares of Astera Labs in a research note on Thursday, April 2nd. They issued a "buy" rating and a $200.00 price target on the stock. Fifteen investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $199.20.

Astera Labs Stock Performance

NASDAQ:ALAB opened at $215.69 on Wednesday. Astera Labs, Inc. has a one year low of $63.40 and a one year high of $262.90. The firm has a market cap of $36.94 billion, a P/E ratio of 176.80, a P/E/G ratio of 3.96 and a beta of 3.35. The firm has a 50-day simple moving average of $140.72 and a 200-day simple moving average of $153.38.

Astera Labs (NASDAQ:ALAB - Get Free Report) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, beating the consensus estimate of $0.54 by $0.07. Astera Labs had a net margin of 25.70% and a return on equity of 16.12%. The business had revenue of $308.36 million during the quarter, compared to analyst estimates of $292.19 million. During the same quarter in the previous year, the business posted $0.33 EPS. The company's quarterly revenue was up 93.5% compared to the same quarter last year. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, research analysts predict that Astera Labs, Inc. will post 1.48 EPS for the current fiscal year.

Trending Headlines about Astera Labs

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Q1 earnings and revenue beat consensus — EPS $0.61 vs. $0.54 est.; revenue $308.4M, up 93% year-over-year and above expectations, showing rapid top-line expansion. Astera Labs Q1 Earnings and Revenues Top Estimates
• Positive Sentiment: Management raised Q2 (FY26 Q2) guidance sharply — EPS guide of $0.680–0.700 vs. street ~$0.50 and revenue guidance ~$355–365M vs. ~$310M consensus, implying continued acceleration into the quarter. Q1 Press Release / Guidance
• Positive Sentiment: Company points to AI spending as a key growth driver and raised investor expectations that demand from hyperscalers and AI customers is sustaining strong order flow. Astera Labs jumps as AI spending buoys Q1 results, guidance
• Positive Sentiment: Product traction: new Scorpio X‑Series 320‑lane smart fabric switch now shipping to leading hyperscalers, supporting the company’s positioning in rack‑scale AI connectivity. Scorpio X-Series Product Release
• Positive Sentiment: Third‑party sentiment and coverage supportive — analysts have an average “Moderate Buy” and prominent commentators (e.g., Jim Cramer) publicly bullish ahead of/around the report, reinforcing investor interest. Analyst Rating Jim Cramer Comment
• Neutral Sentiment: Sector tailwinds: broader chip/semiconductor stocks rallied recently, which likely amplified the stock’s move as investors rotated into AI- and infrastructure-exposed names. Chip Stocks Rally

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.